Testing effectiveness (Phase 2)Study completedNCT00490009What this trial is testingPhase 2 Study of Bexxar in Relapsed/Refractory DLCLWho this might be right forLymphoma Susan Knox 9
Early research (Phase 1)Ended earlyNCT00003567What this trial is testingGene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific Case Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00962507What this trial is testingPanobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forLymphomaMultiple Myeloma and Plasma Cell Neoplasm City of Hope Medical Center 11
Testing effectiveness (Phase 2)Study completedNCT00032019What this trial is testingCombination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Alliance for Clinical Trials in Oncology 78
Testing effectiveness (Phase 2)Study completedNCT00057811What this trial is testingRituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or LymphomaWho this might be right forChildhood Burkitt LymphomaChildhood Diffuse Large Cell LymphomaChildhood Immunoblastic Large Cell Lymphoma+9 more Children's Oncology Group 97
Very early researchLooking for participantsNCT05800405What this trial is testingEvaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma City of Hope Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00004105What this trial is testingCombination Chemotherapy in Treating Patients With Advanced CancerWho this might be right forLeukemiaLymphomaSarcoma+1 more NYU Langone Health
Testing effectiveness (Phase 2)Ended earlyNCT03037645What this trial is testingSafety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid CancersWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaLymphoplasmacytoid Lymphoma+5 more Sunesis Pharmaceuticals 39
Testing effectiveness (Phase 2)UnknownNCT02652910What this trial is testingMemory-enriched CAR-T Cells Immunotherapy for B Cell LymphomaWho this might be right forRecurrent Adult Diffuse Large Cell LymphomaRecurrent Follicular LymphomaRecurrent Mantle Cell Lymphoma+6 more Xinqiao Hospital of Chongqing 20
Not applicableNot Yet RecruitingNCT07498920What this trial is testingGut Microbiome in DLBCL Treated With GlofitamabWho this might be right forDLBCLGlofitamabGut Biome Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00379574What this trial is testingBortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCLWho this might be right forLymphoma, Large-Cell, DiffuseLymphoma, B-Cell Asan Medical Center 49
Not applicableStudy completedNCT01410630What this trial is testingFLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell LymphomaWho this might be right forLymphomaLymphoma, Non-HodgkinLarge B Cell Diffuse Lymphoma Jonsson Comprehensive Cancer Center 66
Large-scale testing (Phase 3)Active Not RecruitingNCT04824092What this trial is testingTafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL PatientsWho this might be right forDiffuse Large B-cell Lymphoma Incyte Corporation 899
Early research (Phase 1)Study completedNCT02343536What this trial is testingA Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed LymphomaWho this might be right forLymphoma, Large B-Cell, DiffuseLymphoma, Follicular Celgene 59
Testing effectiveness (Phase 2)Active Not RecruitingNCT04604067What this trial is testingAssessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.Who this might be right forDiffuse Large B-cell Lymphoma Swiss Cancer Institute 260
Early research (Phase 1)Study completedNCT00049400What this trial is testingS0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific SWOG Cancer Research Network 78
Early research (Phase 1)Study completedNCT04555811What this trial is testingFT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHLWho this might be right forNHLNon Hodgkin LymphomaDiffuse Large B Cell Lymphoma+1 more Masonic Cancer Center, University of Minnesota 7
Early research (Phase 1)Study completedNCT00003082What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Arizona 27
Testing effectiveness (Phase 2)UnknownNCT05290090What this trial is testingZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCLWho this might be right forDiffuse Large B Cell Lymphoma Zhejiang Cancer Hospital 31
Large-scale testing (Phase 3)Study completedNCT00070382What this trial is testingDarbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for CancerWho this might be right forAnemiaLeukemiaLymphoma+4 more Jonsson Comprehensive Cancer Center 14